FREMONT, California, June 24 /PRNewswire/ --

- New Fully-Buffered 800MHz 4GB DIMM Kit Joins Corsair Mac Memory Line

Corsair(R) http://www.corsair.com, a worldwide leader in high performance computer and flash memory products, announced today the launch of their new Mac Memory kits made especially for the newest Mac Pro desktop systems. The new Corsair Mac Memory kits are fully-buffered 800MHz solutions, available immediately in 4GB (2 x 2GB modules) DIMM kits.

Utilizing Mac Pro-specific heat sinks and performance IC's, these new memory modules help unleash the high performance potential of Mac Pro desktop platforms. All Corsair Mac memory modules are qualified at Apple Test Labs in California and are 100% compatibility-guaranteed with a lifetime warranty.

ROUSSET, France, June 24 /PRNewswire/ --

- Extends Atmel's Market-leading AT91SAM Microcontrollers to Next-generation ARM Technology

Atmel(R) Corporation (Nasdaq: ATML) announced today that it has licensed the ARM(R) Cortex(TM)-M3 32-bit RISC processor for the next generation of its market-leading AT91SAM ARM technology-based microcontrollers. This reinforces Atmel's commitment to the ARM architecture, complementing its existing licenses for the ARM7TDMI(R), ARM926EJ-S(TM) and ARM1176JZ-S(TM) processors.

LONDON and CAMBRIDGE, Massachusetts, June 24 /PRNewswire/ --

- Increasing International Demand for Mazu Profiler Catalyst for European Presence and Regional Partnerships -

Mazu Networks, the leading provider of behavior-based, enterprise-class performance and availability solutions, today announced expansion into Europe by establishing a local presence in London and signing strategic partnerships with three leading integrators: Kisdata and Solution Centre in the UK and Nomios in France. Through its London-based office, Mazu Networks can better meet the increasing international demand for Mazu Profiler, the only performance and availability solution based on Network Behavior Analysis (NBA).

ROUSSET, France, June 24 /PRNewswire/ --

- AT73C237 Integrates 4 Linear Regulators in a 3mm x 3mm QFN Package

Atmel(R) Corporation (Nasdaq: ATML) announced today the release of its AT73C237 Power Management Unit (PMU) compatible with a 5V input supply and generating four regulated output voltages, with programmable output voltage selection and output current up to 70mA.

Researchers at Johns Hopkins say that epigenetic marks on DNA - chemical marks other than the DNA sequence - do indeed change over a person's lifetime, and that the degree of change is similar among family members.

The team suggests that overall genome health is heritable and that epigenetic changes occurring over one's lifetime may explain why disease susceptibility increases with age, they say in their article in the June 25 issue of the Journal of the American Medical Association.

If epigenetics does contribute to such diseases through interaction with environment or aging, says Andrew P. Feinberg, M.D., M.P.H, a professor of molecular biology and genetics and director of the Epigenetics Center at the Johns Hopkins School of Medicine, a person's epigenetic marks would change over time. So his team embarked on an international collaboration to see if that was true. They focused on methylation-one particular type of epigenetic mark, where chemical methyl groups are attached to DNA.

REDWOOD CITY, California, June 24 /PRNewswire/ --

- Industry analyst firm MSearchGroove discusses how service providers and mobile operators can compete and win against the Internet giants

Market trends are converging to create a major opportunity for service providers and mobile operators -- mobile email for the mass market. To seize this opportunity, service providers can deploy a solution that is based on open source for the broadest device compatibility, and supported by advertising to foster adoption among cost-conscious users. This is the key message in a new white paper released by Funambol, Inc., the leading provider of Mobile 2.0 messaging software powered by open source.

PLEASANTON, California, June 24 /PRNewswire/ --

- Spigit introduces plug-and-play APIs to instantly extract winning ideas across any and all types of enterprise communications

ADA, Michigan, June 24 /PRNewswire/ --

- World's leading brand of vitamin, mineral and dietary supplements hits record milestone; Amway and Quixtar business owners connect globally with message of optimal health

NUTRILITE, the world's leading brand of vitamin, mineral and dietary supplements, posted a record US$3.1 billion in sales over the last 12 months as Amway/Quixtar's message of optimal health resonates with consumers around the world.

The Centers for Disease Control and Prevention estimates that, in the U.S. alone, foodborne pathogens are responsible for 76 million illnesses every year. Of the people affected by those illnesses, 300,000 are hospitalized and more than 5,000 die. These widespread outbreaks of food-borne illnesses are attributed, in part, to the fast-paced distribution of foods across the nation. Recently, raw tomatoes caused an outbreak of salmonellosis that sickened more than 300 people in at least 28 states and Canada.

University of Georgia researchers have developed an effective technology for reducing contamination of dangerous bacteria on food. The new antimicrobial wash rapidly kills Salmonella and E. coli O157:H7 on foods ranging from fragile lettuce to tomatoes, fruits, poultry products and meats. It is made from inexpensive and readily available ingredients that are recognized as safe by the U.S. Food and Drug Administration.

The new technology, which has commercial application for the produce, poultry, meat and egg processing industries, is available for licensing from the University of Georgia Research Foundation, Inc., which has filed a patent application on the new technology.

NEW YORK, June 24 /PRNewswire/ --

Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) and MRC Technology (MRCT) announced today they have achieved an important milestone through their collaborative efforts to humanize Intellect's lead antibody IN-N01 necessary for creating a therapeutic antibody for the treatment of Alzheimer's disease. The antibody is intended to be used to promote clearance from the brain of beta amyloid, the toxin that leads to Alzheimer's disease. IN-N01 is Intellect's first drug candidate based on the technology invented by Dr. Daniel Chain, the Company's Chairman and CEO.